NAS:CNCR

Range Cancer Therapeutics ETF

$ 15.74 -0.12 ( -0.76%) 03:46 PM EST
PE Ratio:
20.85
PB Ratio:
2.06
Volume:
4.46K
Dividend Yield %:
0
Last Holding update 2024-04-30 80 Stocks (1 new)
Value $19.00 Mil Turnover 18 %
Portfolio Report
Registrant: Range Cancer Therapeutics ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
This section is for PremiumPlus P  Membership subscribers only.
GuruFocus PremiumPlus P  Membership
  Backtesting
  13F, 13D/G of all institutional investors
  Aggregated portfolio of any combinations among them
  FilingWiz
  Manual of Stocks
  Excel Add-In unlimited queries
  API (20,000 queries/month)

Discussions on Range Cancer Therapeutics ETF

How would you rate this stock? CNCR
No discussions yet.